Investigational three-month tuberculosis regimen is safe but ineffective, study finds

The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *